Atlas Trials

BRAF V600E and Redifferentiation Therapy in Radioiodine-refractory Papillary Thyroid Cancer

Clinical trial NCT03363347 · COMPLETED

Trial details

NCT number
NCT03363347
Sponsor
Heidelberg University
Status
COMPLETED
Study type
OBSERVATIONAL
Thyroid Cancer
Start date
2008-01-01
Primary completion
2014-12-31
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.